Results 241 to 250 of about 48,810 (253)

Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME‐1 expression

Histopathology, 1997
Adrian C Bateman, J H Williams, A Herbert   +2 more
exaly  

Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium

Modern Pathology, 2010
Ayuko Sato, Ikuko Torii, Toshiaki Kamei   +2 more
exaly  

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients

Journal of Thoracic and Cardiovascular Surgery, 2008
Raja M Flores, Venkatraman E Seshan, Joseph Dycoco   +2 more
exaly  

Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors

Journal of Thoracic and Cardiovascular Surgery, 2009
Tristan D Yan, Michael Boyer, Daniel Wong   +2 more
exaly  

Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma

Histopathology, 2017
Aya Shinozaki-Ushiku, Tetsuo Ushiku, Masaki Anraku   +2 more
exaly  

Trimodality Treatment of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology, 2008
Muzaffer Metintas, Hale Basak Caglar, Bedrettin Yildizeli   +2 more
exaly  

Malignant mesothelioma in a lamb

Veterinary Record, 1981
P J, Brown, A D, Weaver
openaire   +2 more sources

Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma

Journal of Thoracic Oncology, 2006
Henk C Hoogsteden, Rob J Van Klaveren
exaly  

High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma

Journal of Thoracic Oncology, 2015
Masaki Nasu, Mitsuru Emi, Sandra Pastorino   +2 more
exaly  

Ranpirnase – an antitumour ribonuclease: its potential role in malignant mesothelioma

Expert Opinion on Biological Therapy, 2006
Nick Pavlakis
exaly